Diabetic cardiomyopathy - To take a long story serious

Herz

Volumn 35, Issue 3, 2010, Pages 161-168

  Stratmann, Bernd ^a   Gawlowski, Thomas ^a   Tschoepe, Diethelm ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Diabetic cardiomyopathy; Heart failure; Hyperglycemia; Hyperlipidemia; Myocardial dysfunction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT; CREATINE PHOSPHATE; HEAT SHOCK PROTEIN 27; HEMOGLOBIN A1C; INSULIN RECEPTOR SUBSTRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

DIABETIC CARDIOMYOPATHY; FATTY ACID METABOLISM; GLUCOSE TRANSPORT; GLYCATION; GLYCEMIC CONTROL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; REVIEW;

EID: 77952866159     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3336-0     Document Type: Review

References (76)

1. D. An B. Rodrigues 2006 Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol 291 H1489 506 10.1152/ajpheart.00278.2006 1:CAS:528:DC%2BD28XhtFegtrjO 16751293 (Pubitemid 44497651)
2. H. Ashrafian M.P. Frenneaux L.H. Opie 2007 Metabolic mechanisms in heart failure Circulation 116 434 48 10.1161/CIRCULATIONAHA.107.702795 1:CAS:528:DC%2BD2sXnslKksLs%3D 17646594 (Pubitemid 47196549)
3. L.L. Atkinson M.A. Fischer G.D. Lopaschuk 2002 Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis J Biol Chem 277 29424 30 10.1074/jbc.M203813200 1:CAS:528:DC%2BD38XmsVKitr0%3D 12058043 (Pubitemid 41079226)
4. D.S. Bell 2003 Heart failure: the frequent, forgotten, and often fatal complication of diabetes Diabetes Care 26 2433 41 10.2337/diacare.26.8.2433 12882875 (Pubitemid 36993339)
5. C. Berry M. Brett K. Stevenson 2008 Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure Heart 94 296 304 10.1136/hrt.2006.110999 1:CAS:528:DC%2BD1cXktVKnsbo%3D 17664189 (Pubitemid 351303420)
6. R.J. Bing M.M. Hammond J.C. Handelsman 1949 The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man Am Heart J 38 1 24 10.1016/0002-8703(49)90788-7 1:CAS:528:DyaG3MXpt1Wj 18153124
7. G. Boner M.E. Cooper K. McCarroll 2005 Adverse effects of left ventricular hypertrophy in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study Diabetologia 48 1980 7 10.1007/s00125-005-1893-1 1:CAS:528:DC%2BD2MXhtVyltLbP 16082528 (Pubitemid 41416906)
8. S. Boudina E.D. Abel 2007 Diabetic cardiomyopathy revisited Circulation 115 3213 23 10.1161/CIRCULATIONAHA.106.679597 17592090 (Pubitemid 47012236)
9. J.K. Boyer S. Thanigaraj K.B. Schechtman 2004 Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus Am J Cardiol 93 870 5 10.1016/j.amjcard.2003.12.026 15050491 (Pubitemid 38429599)
10. S.E. Capes D. Hunt K. Malmberg 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 773 8 10.1016/S0140-6736(99)08415-9 1:STN:280:DC%2BD3c7nsFSrtQ%3D%3D 10711923
11. R. Carroll A.N. Carley J.R. Dyck 2005 Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts Am J Physiol Endocrinol Metab 288 E900 6 10.1152/ajpendo.00491.2004 1:CAS:528: DC%2BD2MXktlSgu7s%3D 15632103 (Pubitemid 40547883)
12. H.C. Chiu A. Kovacs R.M. Blanton 2005 Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy Circ Res 96 225 33 10.1161/01.RES.0000154079.20681.B9 1:CAS:528:DC%2BD2MXnt1ensQ%3D%3D 15618539 (Pubitemid 40209370)
13. H.C. Chiu A. Kovacs D.A. Ford 2001 A novel mouse model of lipotoxic cardiomyopathy J Clin Invest 107 813 22 10.1172/JCI10947 1:CAS:528: DC%2BD3MXisFWhsbc%3D 11285300
14. 31P magnetic resonance spectroscopy Lancet 338 973 6 10.1016/0140-6736(91)91838-L 1:CAS:528:DyaK38Xht1Ciu74%3D 1681342
15. S.L. Coort D.M. Hasselbaink D.P. Koonen 2004 Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats Diabetes 53 1655 63 10.2337/diabetes.53.7.1655 1:CAS:528: DC%2BD2cXlslWgtrk%3D 15220187 (Pubitemid 38857021)
16. G. de Simone R.B. Devereux M. Chinali 2009 Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study Nutr Metab Cardiovasc Dis 19 98 104 10.1016/j.numecd.2008.04.001 18674890
17. G. de Simone J.S. Gottdiener M. Chinali 2008 Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur Heart J 29 741 7 10.1093/eurheartj/ehm605 18204091 (Pubitemid 351431013)
18. R.B. Devereux M.J. Roman M. Paranicas 2000 Impact of diabetes on cardiac structure and function: the Strong Heart Study Circulation 101 2271 6 1:STN:280:DC%2BD3c3ntFyhsw%3D%3D 10811594
19. K. Eguchi J. Ishikawa S. Hoshide 2007 Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects Am Heart J 154 79 e9 15 10.1016/j.ahj.2007.04.021 (Pubitemid 46920496)
20. B.N. Finck X. Han M. Courtois 2003 A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content Proc Natl Acad Sci U S A 100 1226 31 10.1073/pnas.0336724100 1:CAS:528:DC%2BD3sXhtF2gtbw%3D 12552126 (Pubitemid 36183984)
21. B.N. Finck J.J. Lehman T.C. Leone 2002 The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus J Clin Invest 109 121 30 1:CAS:528:DC%2BD38XjtlarsQ%3D%3D 11781357
22. T. Gawlowski B. Stratmann I. Stork 2009 Heat shock protein 27 modification is increased in the human diabetic failing heart Horm Metab Res 41 594 9 10.1055/s-0029-1216374 1:CAS:528:DC%2BD1MXhtFyhtr%2FP 19384818
23. H.C. Gerstein M.E. Miller R.P. Byington 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 59 10.1056/NEJMoa0802743 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D 18539917 (Pubitemid 351831356)
24. T.D. Giles G.E. Sander 2004 Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations Cardiol Clin 22 553 68 10.1016/j.ccl.2004.07.002 15501623 (Pubitemid 39402979)
25. L.S. Golfman C.R. Wilson S. Sharma 2005 Activation of PPAR-gamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats Am J Physiol Endocrinol Metab 289 E328 36 10.1152/ajpendo.00055.2005 1:CAS:528:DC%2BD2MXotFajtLo%3D 15797988 (Pubitemid 41076636)
26. C. Guimbal M.W. Kilimann 1993 A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression J Biol Chem 268 8418 21 1:CAS:528:DyaK3sXks1Gqtrg%3D 8473283
27. C.J. Hardy R.G. Weiss P.A. Bottomley 1991 Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy Am Heart J 122 795 801 10.1016/0002-8703(91)90527-O 1:STN:280:DyaK3MzksVygsQ%3D%3D 1877457
28. C. Held H.C. Gerstein S. Yusuf 2007 Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk Circulation 115 1371 5 10.1161/CIRCULATIONAHA.106.661405 1:CAS:528:DC%2BD2sXislaisbw%3D 17339550 (Pubitemid 46648372)
29. T. Horio M. Suzuki I. Takamisawa 2005 Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension Am J Hypertens 18 1626 30 10.1016/j.amjhyper.2005. 05.035 1:CAS:528:DC%2BD2MXhtlCrs7nM 16364837 (Pubitemid 41814687)
30. N. Houstis E.D. Rosen E.S. Lander 2006 Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 944 8 10.1038/nature04634 1:CAS:528:DC%2BD28XjsVWktbw%3D 16612386
31. O.J. How E. Aasum D.L. Severson 2006 Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice Diabetes 55 466 73 10.2337/diabetes.55.02.06.db05-1164 1:CAS:528:DC%2BD28XhsFajsL0%3D 16443782 (Pubitemid 43343277)
32. J.S. Ingwall 2002 Is creatine kinase a target for AMP-activated protein kinase in the heart? J Mol Cell Cardiol 34 1111 20 10.1006/jmcc.2002.2062 1:CAS:528:DC%2BD38XnslGrurY%3D 12392883
33. J.S. Ingwall R.G. Weiss 2004 Is the failing heart energy starved? On using chemical energy to support cardiac function Circ Res 95 135 45 10.1161/01.RES.0000137170.41939.d9 1:CAS:528:DC%2BD2cXls1Gqtbw%3D 15271865 (Pubitemid 38988679)
34. P. Iozzo P. Chareonthaitawee D. Dutka 2002 Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance Diabetes 51 3020 4 10.2337/diabetes.51.10.3020 1:CAS:528:DC%2BD38XnslGhs7c%3D 12351442
35. C. Iribarren A.J. Karter A.S. Go 2001 Glycemic control and heart failure among adult patients with diabetes Circulation 103 2668 73 1:CAS:528: DC%2BD3MXltFCjtbo%3D 11390335
36. M. Kalousova J. Skrha T. Zima 2002 Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus Physiol Res 51 597 604 1:CAS:528:DC%2BD3sXhs1yrtLo%3D 12511184 (Pubitemid 36168668)
37. W.B. Kannel 2000 Incidence and epidemiology of heart failure Heart Fail Rev 5 167 73 10.1023/A:1009884820941 1:STN:280:DC%2BD2MrltVeluw%3D%3D 16228142
38. W.B. Kannel M. Hjortland W.P. Castelli 1974 Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 29 34 10.1016/0002-9149(74)90089-7 1:STN:280:DyaE2c3ltFKrug%3D%3D 4835750
39. W.B. Kannel D.L. McGee 1979 Diabetes and cardiovascular disease. The Framingham study JAMA 241 2035 8 10.1001/jama.241.19.2035 1:STN:280: DyaE1M7lsVCksg%3D%3D 430798 (Pubitemid 9228506)
40. T.D. Karamitsos H.I. Karvounis E.G. Dalamanga 2007 Early diastolic impairment of diabetic heart: the significance of right ventricle Int J Cardiol 114 218 23 10.1016/j.ijcard.2006.02.003 16777248 (Pubitemid 44791510)
41. K.L. King I.C. Okere N. Sharma 2005 Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power Am J Physiol Heart Circ Physiol 289 H1033 7 10.1152/ajpheart.00210.2005 1:CAS:528: DC%2BD2MXhtVWktr7L 15821035 (Pubitemid 41208944)
42. H.J. Lamb H.P. Beyerbacht A. van der Laarse 1999 Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism Circulation 99 2261 7 1:STN:280:DyaK1M3ksVKksA%3D%3D 10226091
43. E. Leyden 1881 Asthma und Diabetes mellitus Z Klin Med 3 358 64
44. J.M. Lopez-Gomez E. Verde R. Perez-Garcia 1998 Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients Kidney Int Suppl 68 S92 8 10.1046/j.1523-1755.1998.06820.x 1:STN:280: DyaK1M%2Fls1Kksg%3D%3D 9839291
45. J. Mayer 1888 Über den Zusammenhang des Diabetes mellitus mit Erkrankungen des Herzens Z Klin Med 14 212 39
46. M. Montagnani 2008 Diabetic cardiomyopathy: how much does it depend on AGE? Br J Pharmacol 154 725 6 10.1038/bjp.2008.121 1:CAS:528: DC%2BD1cXmvFWisrk%3D 18414387 (Pubitemid 351821582)
47. L.D. Monti C. Landoni E. Setola 2004 Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in type 2 diabetic patients Am J Physiol Heart Circ Physiol 287 H1225 31 10.1152/ajpheart.00629.2003 1:CAS:528:DC%2BD2cXnvVaqsb4%3D 15130883 (Pubitemid 39096670)
48. A.J. Murray R.E. Anderson G.C. Watson 2004 Uncoupling proteins in human heart Lancet 364 1786 8 10.1016/S0140-6736(04)17402-3 1:CAS:528: DC%2BD2cXpslGju7Y%3D 15541452 (Pubitemid 39488064)
49. S. Neubauer 2007 The failing heart - an engine out of fuel N Engl J Med 356 1140 51 10.1056/NEJMra063052 17360992 (Pubitemid 46425598)
50. S. Neubauer M. Horn M. Cramer 1997 Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy Circulation 96 2190 6 1:CAS:528:DyaK2sXmvVKrsrs%3D 9337189
51. 31P- magnetic resonance spectroscopy to the understanding of dilated heart muscle disease Eur Heart J 16 SupplO 115 8 1:CAS:528:DyaK28XitlKruro%3D 8682076
52. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure Circulation 86 1810 8 1:STN:280:DyaK3s%2Fot1ymsQ%3D%3D 1451253
53. G.R. Norton G. Candy A.J. Woodiwiss 1996 Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats Circulation 93 1905 12 1:CAS:528:DyaK28Xjs1Sku7k%3D 8635270
54. J.H. O'Keefe D.S. Bell 2007 Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor Am J Cardiol 100 899 904 10.1016/j.amjcard.2007.03.107 17719342 (Pubitemid 47268287)
55. L.H. Opie 1970 Effect of fatty acids on contractility and rhythm of the heart Nature 227 1055 6 10.1038/2271055a0 1:CAS:528:DyaE3cXltVOisLk%3D 5449772
56. A. Patel S. MacMahon J. Chalmers 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 72 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D 18539916 (Pubitemid 351214289)
57. M.A. Quinones B.H. Greenberg H.A. Kopelen 2000 Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 35 1237 44 10.1016/S0735-1097(00)00511-8 1:STN:280:DC%2BD3c3itVOitA%3D%3D 10758966 (Pubitemid 30206899)
58. E.W. Randell S. Vasdev V. Gill 2005 Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography J Pharmacol Toxicol Methods 51 153 7 10.1016/j.vascn.2004.08.005 1:CAS:528:DC%2BD2MXitleku7c%3D 15767209 (Pubitemid 40568606)
59. L.J. Rijzewijk R.W. van der Meer H.J. Lamb 2009 Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging J Am Coll Cardiol 54 1524 32 10.1016/j.jacc.2009.04. 074 1:CAS:528:DC%2BD1MXhsVWqsrfL 19815124
60. P. Rosen X. Du D. Tschope 1998 Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol Cell Biochem 188 103 11 10.1023/A:1006876607566 1:CAS:528:DyaK1cXns1OmtbY%3D 9823016 (Pubitemid 28493323)
61. S. Rubler J. Dlugash Y.Z. Yuceoglu 1972 New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 595 602 10.1016/0002-9149(72)90595-4 1:STN:280:DyaE3s%2FjtFeksA%3D%3D 4263660
62. L. Rui V. Aguirre J.K. Kim 2001 Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways J Clin Invest 107 181 9 10.1172/JCI10934 1:CAS:528:DC%2BD3MXkvVChsA%3D%3D 11160134
63. H.U. Simon A. Haj-Yehia F. Levi-Schaffer 2000 Role of reactive oxygen species (ROS) in apoptosis induction Apoptosis 5 415 8 10.1023/A:1009616228304 1:CAS:528:DC%2BD3MXitV2ru7k%3D 11256882 (Pubitemid 32162623)
64. W.C. Stanley G.D. Lopaschuk J.G. McCormack 1997 Regulation of energy substrate metabolism in the diabetic heart Cardiovasc Res 34 25 33 10.1016/S0008-6363(97)00047-3 1:CAS:528:DyaK2sXktlOlsLc%3D 9217869 (Pubitemid 27261909)
65. I.M. Stratton A.I. Adler H.A. Neil 2000 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405 12 10.1136/bmj.321.7258.405 1:STN:280:DC%2BD3cvisFWnsg%3D%3D 10938048
66. H. Suga 1990 Ventricular energetics Physiol Rev 70 247 77 1:STN:280:DyaK3c3gslCkuw%3D%3D 2181496
67. H. Taegtmeyer P. McNulty M.E. Young 2002 Adaptation and maladaptation of the heart in diabetes. Part I: General concepts Circulation 105 1727 33 10.1161/01.CIR.0000012466.50373.E8 1:CAS:528:DC%2BD38Xjs12nsL4%3D 11940554 (Pubitemid 34298619)
68. J. Uribarri M. Peppa W. Cai 2003 Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients Am J Kidney Dis 42 532 8 10.1016/S0272-6386(03)00779-0 1:CAS:528: DC%2BD3sXnsleisb8%3D 12955681 (Pubitemid 37048129)
69. L. van Heerebeek N. Hamdani M.L. Handoko 2008 Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 43 51 10.1161/CIRCULATIONAHA.107. 728550 18071071 (Pubitemid 350291180)
70. H. Vlassara M.R. Palace 2003 Glycoxidation: the menace of diabetes and aging Mt Sinai J Med 70 232 41 12968196
71. L.E. Wold A.F. Ceylan-Isik J. Ren 2005 Oxidative stress and stress signaling: menace of diabetic cardiomyopathy Acta Pharmacol Sin 26 908 17 10.1111/j.1745-7254.2005.00146.x 1:CAS:528:DC%2BD2MXoslGks7Y%3D 16038622 (Pubitemid 41153210)
72. M. Wyss T. Wallimann 1994 Creatine metabolism and the consequences of creatine depletion in muscle Mol Cell Biochem 133-134 51 66 10.1007/BF01267947 7808465
73. H. Yagyu G. Chen M. Yokoyama 2003 Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy J Clin Invest 111 419 26 12569168
74. M. Yotsukura J. Suzuki T. Yamaguchi 1998 Prognosis following acute myocardial infarction in patients with ECG evidence of left ventricular hypertrophy prior to infarction J Electrocardiol 31 91 9 10.1016/S0022-0736(98) 90039-5 1:STN:280:DyaK1c3kvVSlug%3D%3D 9588654 (Pubitemid 28193837)
75. M.E. Young P. McNulty H. Taegtmeyer 2002 Adaptation and maladaptation of the heart in diabetes. Part II: Potential mechanisms Circulation 105 1861 70 10.1161/01.CIR.0000012467.61045.87 1:CAS:528:DC%2BD38XjvFakt70%3D 11956132 (Pubitemid 34408899)
76. M. Yuan N. Konstantopoulos J. Lee 2001 Reversal of obesityand diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 1673 7 10.1126/science.1061620 1:CAS:528: DC%2BD3MXms1Chtrw%3D 11533494 (Pubitemid 32807849)